Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression In Vivo

被引:19
作者
Beck, Richard J. [1 ]
Slagter, Maarten [1 ]
Beltman, Joost B. [1 ]
机构
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands
关键词
ADOPTIVE TRANSFER; FUNCTIONAL-RESPONSE; INTERFERON-GAMMA; CELL; IMMUNOTHERAPY; MELANOMA; PERFORIN; INFILTRATION; REJECTION; MIGRATION;
D O I
10.1158/0008-5472.CAN-18-3147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunotherapies are an emerging strategy for treatment of solid tumors. Improved understanding of the mechanisms employed by cytotoxic T lymphocytes (CTL) to control tumors will aid in the development of immunotherapies. CTLs can directly kill tumor cells in a contact-dependent manner or may exert indirect effects on tumor cells via secretion of cytokines. Here, we aim to quantify the importance of these mechanisms in murine thymoma EL4/EG7 cells. We developed an agent-based model (ABM) and an ordinary differential equation model of tumor regression after adoptive transfer of a population of CTLs. Models were parameterized based on in vivo measurements of CTL infiltration and killing rates applied to EL4/EG7 tumors and OTI T cells. We quantified whether infiltrating CTLs are capable of controlling tumors through only direct, contact-dependent killing. Both models agreed that the low measured killing rate of CTLs in vivo was insufficient to cause tumor regression. In our ABM, we also simulated CTL production of the cytokine IFN gamma in order to explore how an antiproliferative effect of IFN gamma might aid CTLs in tumor control. In this model, IFN gamma substantially reduced tumor growth compared with direct killing alone. Collectively, these data demonstrate that contact-dependent killing is insufficient for EL4 regression in vivo and highlight the potential importance of cytokine-induced antiproliferative effects in T-cell-mediated tumor control. Significance: Computational modeling highlights the importance of cytokine-induced antiproliferative effects in T-cell-mediated control of tumor progression.
引用
收藏
页码:3406 / 3416
页数:11
相关论文
共 49 条
  • [1] Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
    Ahmed, Nabil
    Brawley, Vita S.
    Hegde, Meenakshi
    Robertson, Catherine
    Ghazi, Alexia
    Gerken, Claudia
    Liu, Enli
    Dakhova, Olga
    Ashoori, Aidin
    Corder, Amanda
    Gray, Tara
    Wu, Meng-Fen
    Liu, Hao
    Hicks, John
    Rainusso, Nino
    Dotti, Gianpietro
    Mei, Zhuyong
    Grilley, Bambi
    Gee, Adrian
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Heslop, Helen E.
    Wels, Winfried S.
    Wang, Lisa L.
    Anderson, Peter
    Gottschalk, Stephen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15) : 1688 - +
  • [2] Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen
    Ariotti, Silvia
    Beltman, Joost B.
    Chodaczek, Grzegorz
    Hoekstra, Mirjam E.
    van Beek, Anna E.
    Gomez-Eerland, Raquel
    Ritsma, Laila
    van Rheenen, Jacco
    Maree, Athanasius F. M.
    Zal, Tomasz
    de Boer, Rob J.
    Haanen, John B. A. G.
    Schumacher, Ton N.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (48) : 19739 - 19744
  • [3] INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR HAVE A ROLE IN TUMOR REGRESSIONS MEDIATED BY MURINE CD8+ TUMOR-INFILTRATING LYMPHOCYTES
    BARTH, RJ
    MULE, JJ
    SPIESS, PJ
    ROSENBERG, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) : 647 - 658
  • [4] Lymph node topology dictates T cell migration behavior
    Beltman, Joost B.
    Maree, Athanasius F. M.
    Lynch, Jennifer N.
    Miller, Mark J.
    de Boer, Rob J.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (04) : 771 - 780
  • [5] Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
    Benci, Joseph L.
    Xu, Bihui
    Qiu, Yu
    Wu, Tony J.
    Dada, Hannah
    Twyman-Saint Victor, Christina
    Cucolo, Lisa
    Lee, David S. M.
    Pauken, Kristen E.
    Huang, Alexander C.
    Gangadhar, Tara C.
    Amaravadi, Ravi K.
    Schuchter, Lynn M.
    Feldman, Michael D.
    Ishwaran, Hemant
    Vonderheide, Robert H.
    Maity, Amit
    Wherry, E. John
    Minn, Andy J.
    [J]. CELL, 2016, 167 (06) : 1540 - +
  • [6] Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
    Besser, Michal J.
    Shapira-Frommer, Ronnie
    Treves, Avraham J.
    Zippel, Dov
    Itzhaki, Orit
    Hershkovitz, Liat
    Levy, Daphna
    Kubi, Adva
    Hovav, Einat
    Chermoshniuk, Natalia
    Shalmon, Bruria
    Hardan, Izhar
    Catane, Raphael
    Markel, Gal
    Apter, Sara
    Ben-Nun, Alon
    Kuchuk, Iryna
    Shimoni, Avichai
    Nagler, Arnon
    Schachter, Jacob
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (09) : 2646 - 2655
  • [7] Solid tumors "melt" from the inside after successful CD8 T cell attack
    Blohm, U
    Potthoff, D
    van der Kogel, AJ
    Pircher, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (02) : 468 - 477
  • [8] In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
    Boissonnas, Alexandre
    Fetler, Luc
    Zeelenberg, Ingrid S.
    Hugues, Stphanie
    Amigorena, Sebastian
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) : 345 - 356
  • [9] Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice
    Breart, Beatrice
    Lemaitre, Fabrice
    Celli, Susanna
    Bousso, Philippe
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (04) : 1390 - 1397
  • [10] Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis
    Briesemeister, Dana
    Sommermeyer, Daniel
    Loddenkemper, Christoph
    Loew, Rainer
    Uckert, Wolfgang
    Blankenstein, Thomas
    Kammertoens, Thomas
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (02) : 371 - 378